← Leaderboards
Ching-Hsuan Tung
Massachusetts General Hospital
$7,201,224
Attributed
$7,413,819
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $747K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,413,819 · 9
By mechanism
R01$4,235,608 · 3
R33$2,281,747 · 2
R21$896,464 · 4
Top collaborators
- Jae-Hyuck Shim2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Tayyaba Hasan$21,611,486
- Jonathan P Celli$3,483,846
- Biju Parekkadan$9,663,657
- Ralph Weissleder$110,468,710
- Gerald P Linette$7,308,810
Others in their field
Top investigators on “Reporter”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReporterDesignBaseIn VivoImageOpticsTumorPathway InteractionsCellsAleuritesProgramsMalignant NeoplasmsFluorescencePrincipal InvestigatorStructureNeoplastic CellCancer CellCytotoxicityCancer TherapyCytotoxicDoseLightEvaluationResearch Study
Grant awards (25)
Novel approach to promote bone formation in osteoporosis using bone-homing mesenchymal stem cells$222,509
R21 · FY2019 · AR · contact PI
Novel approach to promote bone formation in osteoporosis using bone-homing mesenchymal stem cells$202,682
R21 · FY2018 · AR · contact PI
Sound excitable drugs$308,644
R01 · FY2014 · GM · contact PI
Sound excitable drugs$304,920
R01 · FY2012 · GM · contact PI
Dendritic nanomedicine for cancer imaging and treatment$301,913
R01 · FY2012 · CA · contact PI
Sound excitable drugs$304,920
R01 · FY2011 · GM · contact PI
Dendritic nanomedicine for cancer imaging and treatment$301,913
R01 · FY2011 · CA · contact PI
Dendritic nanomedicine for cancer imaging and treatment$311,250
R01 · FY2010 · CA · contact PI
Sound excitable drugs$308,000
R01 · FY2010 · GM · contact PI
Dendritic nanomedicine for cancer imaging and treatment$311,250
R01 · FY2009 · CA · contact PI
Dendritic nanomedicine for cancer imaging and treatment$18,240
R01 · FY2009 · CA · contact PI
Imaging tumor associated fibroblast activation protein$309,507
R33 · FY2008 · CA · contact PI
Dendritic nanomedicine for cancer imaging and treatment$294,650
R01 · FY2008 · CA · contact PI
Imaging tumor associated fibroblast activation protein$360,366
R33 · FY2007 · CA · contact PI
Novel optical probes fir in vivo imaging$375,161
R01 · FY2006 · CA · contact PI
Imaging tumor associated fibroblast activation protein$371,875
R33 · FY2006 · CA · contact PI
Novel optical probes fir in vivo imaging$384,190
R01 · FY2005 · CA
Imaging tumor associated fibroblast activation protein$150,500
R21 · FY2005 · CA
Novel optical probes fir in vivo imaging$362,750
R01 · FY2004 · CA
IN VIVO IMAGING OF MATRIX METALLOPROTEASE$404,078
R33 · FY2003 · CA
Novel optical probes for in vivo imaging$347,807
R01 · FY2003 · CA
IN VIVO IMAGING OF MATRIX METALLOPROTEASE$392,307
R33 · FY2002 · CA
IN VIVO IMAGING OF MATRIX METALLOPROTEASE$443,614
R33 · FY2001 · CA
IN VIVO IMAGING OF MATRIX METALLOPROTEASE$170,805
R21 · FY2000 · CA
MEMBRANE TRANSLOCATION SIGNALS FOR GENE DELIVERY$149,968
R21 · FY2000 · DK